drugset / Trial / NCT04646135
Lorazepam for the Analgosedation of Pediatric Patients in Mechanical Ventilation.
Phase 2
Unknown
9 enrolled
Bambino Gesù Hospital and Research Institute
Ministero della Salute, Italy · collabUniversity College, London · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
The aim of this study is to better define the pharmacokinetic and pharmacodynamic profile of lorazepam for the analgosedation in pediatric intensive care unit. This will help to better define the dosages and administration modalities (bolus or continue infusion) required to achieve analgosedation with lorazepam in pediatric patients undergoing mechanical ventilation.
Timeline
- Start
- 2020-12
- Primary completion
- 2021-07
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorazepam | Small molecule | 0.025 mg/kg | Intravenous |
| Subject | Lorazepam | Small molecule | 0.03 mg/kg | Intravenous |
Indications
No indication recorded.